Ico Therapeutics, Inc.

Ordinary Shares International Reporting
Verified Company Profile 1/31/2017
Contact Info
  • 777 Hornby Street
  • 6th Floor
  • Vancouver, BC V6Z 1S4
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Mar 31, 2017 Quarterly Report
CIK 0001421642
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: British Columbia, Canada
Year of Inc. 2005
Employees 5 a/o Jul 31, 2016
Company Officers/Contacts
Andrew Rae President, CEO
Michael Liggett CFO
Peter Hnik Chief Med. Officer
Company Directors
William Jarosz
Susan Koppy
Andrew Rae
Service Providers
Accounting/Auditing Firm
PricewaterhouseCoopers LLP
250 Howe Street
Suite 700
Vancouver, BC, V6C 3S7
Securities Counsel
Blakes, Cassels & Graydon LLP
595 Burrard Street
PO Box 49314
Vancouver, BC, V7X 1L3
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by Troutman Sanders LLP on 12/19/2013
ICOTF Security Details
Share Structure
Market Value1 $2,922,237 a/o Jun 23, 2017
Authorized Shares Unlimited a/o Jan 30, 2017
Outstanding Shares 84,457,713 a/o Apr 19, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 79,904,458 a/o Jan 30, 2017
Par Value No Par Value
Shareholders of Record Not Available
Non US Stock Exchange Listing
ICO - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 22,758 (0%)
Mar 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security